global hodgkin's lymphoma therapeutics market 2014-2018
DESCRIPTION
Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. TechNavio's report, the Global Hodgkin's Lymphoma Therapeutics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts.TechNavio's analysts forecast the Global Hodgkin's Lymphoma Therapeutics market will grow at a CAGR of 6.84 percent over the period 2013-2018.TRANSCRIPT
Global Hodgkin's Lymphoma Therapeutics Market 2014-2018
TechNavio Insights
USA – CANADA – UK – CHINA – INDIA
Market Overview: Hodgkin's Lymphoma Therapeutics
About Hodgkin's Lymphoma Therapeutics • Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system.
• The exact etiology of HL is unknown. However, the risk of developing the condition is increased if a person suffers from a medical condition that weakens the immune system.
• In HL, cells in the lymphatic system grow unusually and may spread beyond the lymphatic system.
• The infection-fighting properties of the lymphocytes are lost, making the person more susceptible to infection.
• The main treatments used are chemotherapy, followed by radiotherapy or chemotherapy alone.
• Generally surgery is not used as a treatment for the condition.
• TechNavio's analysts forecast the Global Hodgkin's Lymphoma Therapeutics market will grow at a CAGR of 6.84 percent over the period 2013-2018.
USA – CANADA – UK – CHINA – INDIA
Covered in This Report
• The Global Hodgkin's Lymphoma Therapeutics market can be divided into eight segments: Alkylating Antineoplastic Agents, Antibiotic Antineoplastic Agents, Antineoplastics Vinca Alkaloid Agents, Podophyllotoxin Derivative Antineoplastic Agents, Antimetabolite Antineoplastic Agents, Anthracycline Antineoplastic Agents, Antimicrotubular Antineoplastics, and Corticosteroids.
• To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of HL that are available in the market.
• TechNavio's report, the Global Hodgkin's Lymphoma Therapeutics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts.
• The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Hodgkin's Lymphoma Therapeutics market landscape and its growth prospects in the coming years.
• The report also includes a discussion of the key vendors operating in this market.
USA – CANADA – UK – CHINA – INDIA
Key Regions
Americas
APAC
EMEA
USA – CANADA – UK – CHINA – INDIA
Key Vendors
Key Vendors• Bristol Myers Squibb Co.• F. Hoffmann-La Roche Ltd.• Merck & Co. Inc.• Pfizer Inc.
Other Prominent Vendors• 4SC AG• Actinium Pharmaceuticals Inc.• Aeterna Zentaris Inc.• Affimed Therapeutics AG• Hospira Inc.• Incyte Corp.• Novartis AG• Philogen S.p.A.• Seattle Genetics Inc.• Sigma-Tau Pharmaceuticals Inc.• Stemline Therapeutics Inc.• Teva Pharmaceutical Industries Ltd.
USA – CANADA – UK – CHINA – INDIA
Market Drivers, Challenges and Trends
Guest BloggersDriver• Improved Diagnostic Techniques.• For a full, detailed list, view our report.
Challenge
• High Cost.• For a full, detailed list, view our report.
Trend
• Increase in Awareness of HL.• For a full, detailed list, view our report.
A detailed analysis of each market driver, challenge and trend is
available in our report:
Global Hodgkin's Lymphoma Therapeutics Market 2014-2018
USA – CANADA – UK – CHINA – INDIA
Key Questions
Questions Answered in Our Report• What will the market size be in 2018 and what will the growth rate be?• What are the key market trends?• What is driving this market?• What are the challenges to market growth?• Who are the key vendors in this market space?• What are the market opportunities and threats faced by the key
vendors?• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
USA – CANADA – UK – CHINA – INDIA
View Our Report
Global Hodgkin's Lymphoma Therapeutics Market 2014-2018
View Report >>
TechNavio's report, Global Hodgkin's Lymphoma Therapeutics Market 2014-2018 , has been prepared based on an in-depth market analysis with inputs from industry experts.
Published on: August 06, 2014 | 79 Pages | SKU: IRTNTR3907
USA – CANADA – UK – CHINA – INDIA
India: An Overview
USA – CANADA – UK – CHINA – INDIA
More than 2500 Reports in Niche Domains
by 200 Analysts located Globally
In Operation for More than
10 Years with Offices in London, Chicago, Toronto, Beijing &
Bangalore
Cover More than 500 Emerging New
Technologies across 80 Countries in US, EMEA &
APAC Regions
Reports Cover : Market Scenarios, Vendor landscape & Industry Road Maps.Option to Customize Report & Access to Analysts on every Report Purchase.
About Us
USA – CANADA – UK – CHINA – INDIA
Access the Report
USA – CANADA – UK – CHINA – INDIA
India: An Overview
USA – CANADA – UK – CHINA – INDIA
About Us
USA – CANADA – UK – CHINA – INDIA
Thank You!
North America
Chicago, USA
Phone: +1 630 333 9501
Fax: +1 630 833 2171
Europe
London, United Kingdom
Phone: +44 208 123 1770
Fax: +44 845 280 2825
Asia
Bangalore, India
Phone: +91 934 254 0560
Fax: +91 80 4080 6070
Mail us at: [email protected]
You can visit us at:www.technavio.com
DISCLAIMER
This presentation is intended solely for showcasing Infiniti’s research capabilities. All information contained within this presentation has been randomized and should not be used for any kind of analysis and/or for decision making purpose. All trademarks and copyrights remain the sole ownership of their rightful owners/licensees. In no event shall Infiniti Research have any liability to any party for special, incidental, tort, or consequential damages arising out of
or in connection with this report, even if Infiniti Research has been advised of the possibility of such damages.
Copyright ©2013 Infiniti Research Limited. All Rights Reserved.
Reproduction without written permission is completely forbidden.
NOT FOR FURTHER DISTRIBUTION